A citation-based method for searching scientific literature

Patrick J Killela, Zachary J Reitman, Yuchen Jiao, Chetan Bettegowda, Nishant Agrawal, Luis A Diaz, Allan H Friedman, Henry Friedman, Gary L Gallia, Beppino C Giovanella, Arthur P Grollman, Tong-Chuan He, Yiping He, Ralph H Hruban, George I Jallo, Nils Mandahl, Alan K Meeker, Fredrik Mertens, George J Netto, B Ahmed Rasheed, Gregory J Riggins, Thomas A Rosenquist, Mark Schiffman, Ie-Ming Shih, Dan Theodorescu, Michael S Torbenson, Victor E Velculescu, Tian-Li Wang, Nicolas Wentzensen, Laura D Wood, Ming Zhang, Roger E McLendon, Darell D Bigner, Kenneth W Kinzler, Bert Vogelstein, Nickolas Papadopoulos, Hai Yan. Proc Natl Acad Sci U S A 2013
Times Cited: 841







List of co-cited articles
788 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas.
Sumihito Nobusawa, Takuya Watanabe, Paul Kleihues, Hiroko Ohgaki. Clin Cancer Res 2009
445
4

Suppression of the alternative lengthening of telomere pathway by the chromatin remodelling factor ATRX.
David Clynes, Clare Jelinska, Barbara Xella, Helena Ayyub, Caroline Scott, Matthew Mitson, Stephen Taylor, Douglas R Higgs, Richard J Gibbons. Nat Commun 2015
127
4

DNA methylation-based classification of central nervous system tumours.
David Capper, David T W Jones, Martin Sill, Volker Hovestadt, Daniel Schrimpf, Dominik Sturm, Christian Koelsche, Felix Sahm, Lukas Chavez, David E Reuss,[...]. Nature 2018
688
4

Targeting telomerase for cancer therapy.
Adam N Guterres, Jessie Villanueva. Oncogene 2020
9
44

A restricted cell population propagates glioblastoma growth after chemotherapy.
Jian Chen, Yanjiao Li, Tzong-Shiue Yu, Renée M McKay, Dennis K Burns, Steven G Kernie, Luis F Parada. Nature 2012
3

Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo.
Isaac Marin-Valencia, Chendong Yang, Tomoyuki Mashimo, Steve Cho, Hyeonman Baek, Xiao-Li Yang, Kartik N Rajagopalan, Melissa Maddie, Vamsidhara Vemireddy, Zhenze Zhao,[...]. Cell Metab 2012
324
3

Most human non-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma.
Tatsuya Ozawa, Markus Riester, Yu-Kang Cheng, Jason T Huse, Massimo Squatrito, Karim Helmy, Nikki Charles, Franziska Michor, Eric C Holland. Cancer Cell 2014
227
3

Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors.
David Capper, Susanne Weissert, Jörg Balss, Antje Habel, Jochen Meyer, Diana Jäger, Ulrike Ackermann, Claudia Tessmer, Andrey Korshunov, Hanswalter Zentgraf,[...]. Brain Pathol 2010
366
3


Mutations of the TERT promoter are common in basal cell carcinoma and squamous cell carcinoma.
Glynis A Scott, Todd S Laughlin, Paul G Rothberg. Mod Pathol 2014
65
4

Signatures of mutational processes in human cancer.
Ludmil B Alexandrov, Serena Nik-Zainal, David C Wedge, Samuel A J R Aparicio, Sam Behjati, Andrew V Biankin, Graham R Bignell, Niccolò Bolli, Ake Borg, Anne-Lise Børresen-Dale,[...]. Nature 2013
3

Comprehensive genetic alteration profiling in primary and recurrent glioblastoma.
Beth K Neilsen, Richard Sleightholm, Rodney McComb, Shakti H Ramkissoon, Jeffrey S Ross, Robert J Corona, Vincent A Miller, Matthew Cooke, Michele R Aizenberg. J Neurooncol 2019
13
23

A highly selective telomerase inhibitor limiting human cancer cell proliferation.
K Damm, U Hemmann, P Garin-Chesa, N Hauel, I Kauffmann, H Priepke, C Niestroj, C Daiber, B Enenkel, B Guilliard,[...]. EMBO J 2001
308
3

Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma.
Brett E Johnson, Tali Mazor, Chibo Hong, Michael Barnes, Koki Aihara, Cory Y McLean, Shaun D Fouse, Shogo Yamamoto, Hiroki Ueda, Kenji Tatsuno,[...]. Science 2014
754
3

Highly prevalent TERT promoter mutations in aggressive thyroid cancers.
Xiaoli Liu, Justin Bishop, Yuan Shan, Sara Pai, Dingxie Liu, Avaniyapuram Kannan Murugan, Hui Sun, Adel K El-Naggar, Mingzhao Xing. Endocr Relat Cancer 2013
353
3

Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma.
Jianxin Shi, Xiaohong R Yang, Bari Ballew, Melissa Rotunno, Donato Calista, Maria Concetta Fargnoli, Paola Ghiorzo, Brigitte Bressac-de Paillerets, Eduardo Nagore, Marie Francoise Avril,[...]. Nat Genet 2014
185
3

Neural stem cells and the origin of gliomas.
Nader Sanai, Arturo Alvarez-Buylla, Mitchel S Berger. N Engl J Med 2005
689
3

Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma.
Frank B Furnari, Timothy F Cloughesy, Webster K Cavenee, Paul S Mischel. Nat Rev Cancer 2015
187
3

Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion.
Kensuke Tateishi, Hiroaki Wakimoto, A John Iafrate, Shota Tanaka, Franziska Loebel, Nina Lelic, Dmitri Wiederschain, Olivier Bedel, Gejing Deng, Bailin Zhang,[...]. Cancer Cell 2015
187
3

An interaction proteomics survey of transcription factor binding at recurrent TERT promoter mutations.
Matthew M Makowski, Esther Willems, Jun Fang, Jiyeon Choi, Tongwu Zhang, Pascal W T C Jansen, Kevin M Brown, Michiel Vermeulen. Proteomics 2016
29
10

Frequency of TERT promoter mutations in primary tumors of the liver.
Alexander Quaas, Theresa Oldopp, Lars Tharun, Catina Klingenfeld, Till Krech, Guido Sauter, Tobias J Grob. Virchows Arch 2014
35
8

Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy.
HuyTram N Nguyen, Amy Lie, Tie Li, Reshmi Chowdhury, Fei Liu, Byram Ozer, Bowen Wei, Richard M Green, Benjamin M Ellingson, He-Jing Wang,[...]. Neuro Oncol 2017
43
6

Preclinical and clinical implications of TERT promoter mutation in glioblastoma multiforme.
Da Eun Jeong, Seon Rang Woo, Hyun Nam, Do-Hyun Nam, Jae-Ho Lee, Kyeung Min Joo. Oncol Lett 2017
8
37


Telomere shortening and growth inhibition of human cancer cells by novel synthetic telomerase inhibitors MST-312, MST-295, and MST-1991.
Hiroyuki Seimiya, Tomoko Oh-hara, Tsuneji Suzuki, Imad Naasani, Toshiyuki Shimazaki, Katsutoshi Tsuchiya, Takashi Tsuruo. Mol Cancer Ther 2002
95
3

Rapid and reversible suppression of ALT by DAXX in osteosarcoma cells.
Kathryn E Yost, Sarah F Clatterbuck Soper, Robert L Walker, Marbin A Pineda, Yuelin J Zhu, Corbin D Ester, Soyeon Showman, Anna V Roschke, Joshua J Waterfall, Paul S Meltzer. Sci Rep 2019
14
21

Myc activates telomerase.
J Wang, L Y Xie, S Allan, D Beach, G J Hannon. Genes Dev 1998
531
3

TERT Promoter Mutations and Risk of Recurrence in Meningioma.
Felix Sahm, Daniel Schrimpf, Adriana Olar, Christian Koelsche, David Reuss, Juliane Bissel, Annekathrin Kratz, David Capper, Sebastian Schefzyk, Thomas Hielscher,[...]. J Natl Cancer Inst 2015
146
3

Identification of ATPases pontin and reptin as telomerase components essential for holoenzyme assembly.
Andrew S Venteicher, Zhaojing Meng, Philip J Mason, Timothy D Veenstra, Steven E Artandi. Cell 2008
219
3

A mechanistic classification of clinical phenotypes in neuroblastoma.
Sandra Ackermann, Maria Cartolano, Barbara Hero, Anne Welte, Yvonne Kahlert, Andrea Roderwieser, Christoph Bartenhagen, Esther Walter, Judith Gecht, Laura Kerschke,[...]. Science 2018
72
4

Regulation of the Human Telomerase Gene TERT by Telomere Position Effect-Over Long Distances (TPE-OLD): Implications for Aging and Cancer.
Wanil Kim, Andrew T Ludlow, Jaewon Min, Jerome D Robin, Guido Stadler, Ilgen Mender, Tsung-Po Lai, Ning Zhang, Woodring E Wright, Jerry W Shay. PLoS Biol 2016
77
3

BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence.
Mingzhao Xing, Rengyun Liu, Xiaoli Liu, Avaniyapuram Kannan Murugan, Guangwu Zhu, Martha A Zeiger, Sara Pai, Justin Bishop. J Clin Oncol 2014
372
3

Telomeres and telomerase in head and neck squamous cell carcinoma: from pathogenesis to clinical implications.
Paolo Boscolo-Rizzo, Maria Cristina Da Mosto, Enrica Rampazzo, Silvia Giunco, Annarosa Del Mistro, Anna Menegaldo, Lorena Baboci, Monica Mantovani, Giancarlo Tirelli, Anita De Rossi. Cancer Metastasis Rev 2016
27
11

Heterogeneity of TERT promoter mutations status in squamous cell carcinomas of different anatomical sites.
Katherine A Cheng, Boaz Kurtis, Sabina Babayeva, Jian Zhuge, Irlna Tantchou, Dongming Cai, Rocco J Lafaro, John T Fallon, Minghao Zhong. Ann Diagn Pathol 2015
23
13

TERT promoter mutations predict worse survival in laryngeal cancer patients.
Yiping Qu, Siwen Dang, Kexia Wu, Yuan Shao, Qi Yang, Meiju Ji, Bingyin Shi, Peng Hou. Int J Cancer 2014
31
9

The Molecular Landscape of Recurrent and Metastatic Head and Neck Cancers: Insights From a Precision Oncology Sequencing Platform.
Luc G T Morris, Raghu Chandramohan, Lyndsay West, Ahmet Zehir, Debyani Chakravarty, David G Pfister, Richard J Wong, Nancy Y Lee, Eric J Sherman, Shrujal S Baxi,[...]. JAMA Oncol 2017
115
3

Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.
J Ferlay, M Colombet, I Soerjomataram, C Mathers, D M Parkin, M Piñeros, A Znaor, F Bray. Int J Cancer 2019
3

The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism.
Rui Batista, Adriana Cruvinel-Carloni, João Vinagre, Joana Peixoto, Telmo A Catarino, Nathalia Cristina Campanella, Weder Menezes, Aline Paixão Becker, Gisele Caravina de Almeida, Marcus M Matsushita,[...]. Int J Cancer 2016
35
8

Hypermethylation of the human telomerase catalytic subunit (hTERT) gene correlates with telomerase activity.
Isabelle Guilleret, Pu Yan, Fabienne Grange, Richard Braunschweig, Fred T Bosman, Jean Benhattar. Int J Cancer 2002
172
3

A DNA damage checkpoint response in telomere-initiated senescence.
Fabrizio d'Adda di Fagagna, Philip M Reaper, Lorena Clay-Farrace, Heike Fiegler, Philippa Carr, Thomas Von Zglinicki, Gabriele Saretzki, Nigel P Carter, Stephen P Jackson. Nature 2003
3

Telomerase activity in human germline and embryonic tissues and cells.
W E Wright, M A Piatyszek, W E Rainey, W Byrd, J W Shay. Dev Genet 1996
947
3

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.
Christian Hartmann, Jochen Meyer, Jörg Balss, David Capper, Wolf Mueller, Arne Christians, Jörg Felsberg, Marietta Wolter, Christian Mawrin, Wolfgang Wick,[...]. Acta Neuropathol 2009
762
3

Analysis of the IDH1 codon 132 mutation in brain tumors.
Jörg Balss, Jochen Meyer, Wolf Mueller, Andrey Korshunov, Christian Hartmann, Andreas von Deimling. Acta Neuropathol 2008
726
3

TERT promoter mutations contribute to subset prognostication of lower-grade gliomas.
Aden Ka-Yin Chan, Yu Yao, Zhenyu Zhang, Nellie Yuk-Fei Chung, Joseph Shu-Ming Liu, Kay Ka-Wai Li, Zhifeng Shi, Danny Tat-Ming Chan, Wai Sang Poon, Liangfu Zhou,[...]. Mod Pathol 2015
71
4


DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors.
Yuchen Jiao, Chanjuan Shi, Barish H Edil, Roeland F de Wilde, David S Klimstra, Anirban Maitra, Richard D Schulick, Laura H Tang, Christopher L Wolfgang, Michael A Choti,[...]. Science 2011
3

IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas.
Takuya Watanabe, Sumihito Nobusawa, Paul Kleihues, Hiroko Ohgaki. Am J Pathol 2009
650
3

Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma.
Itay Tirosh, Andrew S Venteicher, Christine Hebert, Leah E Escalante, Anoop P Patel, Keren Yizhak, Jonathan M Fisher, Christopher Rodman, Christopher Mount, Mariella G Filbin,[...]. Nature 2016
369
3

Targeting G-quadruplexes in gene promoters: a novel anticancer strategy?
Shankar Balasubramanian, Laurence H Hurley, Stephen Neidle. Nat Rev Drug Discov 2011
970
3

A Pharmacological Chaperone Molecule Induces Cancer Cell Death by Restoring Tertiary DNA Structures in Mutant hTERT Promoters.
Hyun-Jin Kang, Yunxi Cui, Holly Yin, Amy Scheid, William P D Hendricks, Jessica Schmidt, Aleksandar Sekulic, Deming Kong, Jeffrey M Trent, Vijay Gokhale,[...]. J Am Chem Soc 2016
46
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.